Prime Medix Enterprises

20/09/2026

Installation and commissioning of PHILIPS MR5300, 1.5 Tesla 🙏 🙏 🙏

30/07/2026

Installation and commissiong of Philips Zenition 70 mobile C-Arm. Equipped with an advanced mobile x-ray and fluoroscopy system that uses fourth-generation flat detector technology to provide clear, real time imaging during surgery

25/07/2026

Society for Obstetric Anesthesia of the Philippines,
34th Midyear Convention.

23/07/2026

25th Association of Respiratory Care Practitioners Phils (ARCPP)

19/07/2026

Early Detection of Liver Cancer Using the GALAD Score
The GALAD score is a validated blood-based model used to support the early detection of hepatocellular carcinoma (HCC), the most common primary liver cancer. It combines patient demographic factors—gender and age—with three serum biomarkers: alpha-fetoprotein (AFP), AFP-L3%, and des-gamma-carboxy prothrombin (DCP or PIVKA-II).
By integrating these variables, the GALAD score improves the identification of HCC, particularly in patients with chronic liver disease or cirrhosis who are at high risk of developing liver cancer. Studies have shown that the GALAD score can detect early-stage HCC with higher sensitivity than AFP alone, including tumors that may not yet be visible on routine imaging.
As a non-invasive blood test, the GALAD score may serve as a useful adjunct to ultrasound surveillance, helping clinicians identify patients who require further diagnostic evaluation. Early detection is critical because HCC identified at an early stage is more likely to be treated with curative options such as surgical resection, liver transplantation, or local ablative therapy.
Overall, the GALAD score represents a promising tool for enhancing liver cancer surveillance and improving outcomes through earlier diagnosis. Fujifilm Philippines Medical Systems

04/07/2026

Gripper Plus, Power P.A.C Safety Huber Needles

Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.

02/07/2026

The UTAS-Wako GALAD Score is a validated diagnostic algorithm used to improve the early detection of hepatocellular carcinoma (HCC), the most common form of primary liver cancer. It combines patient demographics (Gender and Age) with three serum biomarkers—Alpha-fetoprotein (AFP), AFP-L3%, and Des-gamma-carboxy prothrombin (DCP/PIVKA-II)—to generate a risk score for HCC. Compared with the use of AFP alone or conventional imaging surveillance, the GALAD Score has demonstrated higher sensitivity and specificity for detecting early-stage liver cancer, including tumors that may not yet be visible on imaging. The UTAS-Wako platform provides standardized measurement of these biomarkers, making the GALAD Score a valuable adjunct in the surveillance of high-risk patients with chronic liver disease or cirrhosis. It is intended to complement, rather than replace, imaging modalities and clinical evaluation.
For more info, please direct message us

Fujifilm Philippines Medical Systems

26/06/2026

ICU Medical (Deltec) the innovator of Totally Implantable Venous Access Device (TIVAD) or most commonly known as Port-a-Cath and Gripper Plus Huber needles, is now available in the Philippines. For more info please contact our customer service

21/06/2026

Happy Father’s Day from Prime Medix

19/06/2026

Installation of Fujifilm’s Eluxeo 7000 with CAD EYE Artificial Intelligence endoscopy system and Sonosite ZX pocus. Thank you Lord 🙏